SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-24-000048
Filing Date
2024-03-28
Accepted
2024-03-28 17:00:54
Documents
17
Period of Report
2024-03-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20240326.htm   iXBRL 8-K 50208
2 EX-3.1 exhibit31certificateofamen.htm EX-3.1 19250
3 EX-3.2 exhibit32certificateofamen.htm EX-3.2 11249
4 EX-99.1 exhibit991_03282024pressre.htm EX-99.1 14508
8 logoa.jpg GRAPHIC 15745
  Complete submission text file 0001453687-24-000048.txt   261086

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240326.xsd EX-101.SCH 1981
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240326_lab.xml EX-101.LAB 22788
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240326_pre.xml EX-101.PRE 13107
20 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240326_htm.xml XML 2828
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 24800135
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)